| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450018 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450019 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450020 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450021 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450022 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450023 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450024 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450025 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450026 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450027 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450028 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450029 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABRON RETARD 200 mg | TRAMADOLUM | COMPR. CU ELIB. PREL. | N02AX02 | W61450030 | MEDOCHEMIE LTD. - CIPRU | ||||||
| MABTHERA 500 mg | RITUXIMABUM | CONC. PT. SOL. PERF. | L01FA01 | W64386001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| MABTHERA 100 mg | RITUXIMABUM | CONC. PT. SOL. PERF. | L01FA01 | W64385001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| MABTHERA 1400 mg | RITUXIMABUM | SOL. INJ. | L01FA01 | W64387001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| MABTHERA 1600 mg | RITUXIMABUM | SOL. INJ. | L01FA01 | W66651001 | ROCHE REGISTRATION GMBH - GERMANIA | X | |||||
| MACMIROR COMPLEX 100 mg+40000 UI/g | COMBINATII (NIFURATELUM+NYSTATINUM) | CREMA VAG. | G01AA51 | W51914001 | POLICHEM SA - LUXEMBURG | ||||||
| MACMIROR COMPLEX 500 mg/200000 UI | COMBINATII (NIFURATELUM+NYSTATINUM) | CAPS. MOI VAG. | G01AA51 | W51716002 | POLICHEM SA - LUXEMBURG | ||||||
| MADOPAR 200mg/50mg | COMBINATII (LEVODOPUM+BENSERAZIDUM) | COMPR. | N04BA02 | W58811002 | ROCHE ROMANIA S.R.L. - ROMANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman